강스템바이오텍: management transactions · South Korea · DART (FSS)

Browse the full directors' dealings record of 강스템바이오텍, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €218.2bn. The latest transaction was filed on 3 April 2026 — Purchase. Among the most active insiders: 강경선. All data is accessible without an account.